Published in BMC Cancer on October 19, 2015
Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics (2016) 0.79
DNA methylation assay for colorectal carcinoma. Cancer Biol Med (2017) 0.75
Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. Clin Epigenetics (2017) 0.75
THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer. Sci Rep (2016) 0.75
Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. World J Gastroenterol (2016) 0.75
A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function. Sci Rep (2017) 0.75
Identification of common molecular subsequences. J Mol Biol (1981) 130.53
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
An improved algorithm for matching biological sequences. J Mol Biol (1982) 21.95
miR-21-mediated tumor growth. Oncogene (2006) 9.90
Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res (1998) 8.95
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform (2011) 8.50
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
DNA methylation analysis by pyrosequencing. Nat Protoc (2007) 4.65
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology (2008) 4.38
Direct comparisons of Illumina vs. Roche 454 sequencing technologies on the same microbial community DNA sample. PLoS One (2012) 2.68
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet (1991) 2.45
DNA methylation markers in colorectal cancer. Cancer Metastasis Rev (2010) 2.40
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion (2011) 1.85
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res (2004) 1.69
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut (2009) 1.65
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene (2007) 1.63
BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res (2005) 1.58
The role of microRNAs in colorectal cancer. Cancer J (2012) 1.44
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res (2003) 1.36
Serial pyrosequencing for quantitative DNA methylation analysis. Biotechniques (2006) 1.34
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers (2008) 1.24
Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int (2012) 1.24
Genome-wide DNA methylation scan in major depressive disorder. PLoS One (2012) 1.17
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol (2008) 1.16
DNA hypermethylation near the transcription start site of collagen alpha2(I) gene occurs in both cancer cell lines and primary colorectal cancers. Cancer Res (2003) 1.16
Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One (2011) 1.11
Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer (1999) 1.09
IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis (2012) 1.09
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene (1999) 1.08
CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer. Int J Oncol (2009) 1.04
Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One (2012) 1.01
Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One (2013) 1.00
Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons. J Biol Chem (2010) 0.99
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance. Eur J Cancer (2008) 0.94
Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol (2007) 0.93
Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One (2012) 0.92
Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential. Epigenetics (2013) 0.91
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. Mol Cancer Ther (2013) 0.88
Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer. Cancer Biomark (2012) 0.84
Cytokine-induced chromatin modifications of the type I collagen alpha 2 gene during intestinal endothelial-to-mesenchymal transition. Inflamm Bowel Dis (2013) 0.84
Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect. PLoS One (2014) 0.83
Collagen type I expression in experimental anaplastic thyroid carcinoma: regulation and relevance for tumorigenicity. Int J Cancer (2002) 0.83
Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. Anticancer Res (2001) 0.83
Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells. Oncol Rep (2013) 0.78
Mutational screening of the SOCS3 gene promoter in metastatic colorectal cancer patients. Genet Test Mol Biomarkers (2012) 0.78
SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients. PLoS One (2014) 0.78
Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer (2015) 0.87
Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples. Diagn Pathol (2015) 0.77